Close

Merck (MRK) Announces FDA Approves New Monotherapy Indication for its KEYTRUDA

July 31, 2019 6:46 AM EDT Send to a Friend
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login